KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to 0.73.

  • Inovio Pharmaceuticals' Debt Ratio changed N/A to 0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73, marking a year-over-year change of. This contributed to the annual value of 0.12 for FY2024, which is 1936.39% up from last year.
  • As of Q3 2025, Inovio Pharmaceuticals' Debt Ratio stood at 0.73.
  • Inovio Pharmaceuticals' 5-year Debt Ratio high stood at 0.73 for Q3 2025, and its period low was 0.0 during Q3 2021.
  • Moreover, its 5-year median value for Debt Ratio was 0.06 (2023), whereas its average is 0.1.
  • Per our database at Business Quant, Inovio Pharmaceuticals' Debt Ratio plummeted by 4945.93% in 2021 and then surged by 236045.66% in 2023.
  • Quarter analysis of 5 years shows Inovio Pharmaceuticals' Debt Ratio stood at 0.0 in 2021, then surged by 277.2% to 0.0 in 2022, then surged by 2253.6% to 0.1 in 2023, then grew by 19.36% to 0.12 in 2024, then soared by 520.12% to 0.73 in 2025.
  • Its last three reported values are 0.73 in Q3 2025, 0.17 for Q2 2025, and 0.11 during Q1 2025.